Accelerating research and development activities
First written in FY2019. 11 of 22 entries say "Advanced", first in FY2020. Latest entry: FY2026.
59 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Total research and development expenses for the fiscal year were ¥1,499.395 million, accounting for 75.0% of total operating expenses. The Company plans to accelerate its research and development activities going forward and expects to incur a commensurate level of research and development expenses.」
Research and development expenses increased from ¥1,394.651 million in the previous fiscal year to ¥1,499.395 million, and accounted for 75.0% of operating expenses. The policy of accelerating research and development activities remains in place. - FY2026-H1AdvancedAnnual report
「The company's total research and development expenses for the interim accounting period were ¥748.507 million (compared with ¥739.576 million in the same period of the previous year). During the interim accounting period, the company promoted research and development as described in “(1) Operating Results.”」
Research and development expenses increased from ¥739.576 million in the same period of the previous year to ¥748.507 million, and the company continued to promote research and development. - FY2025RestatedAnnual report
「The company's total research and development expenses for the fiscal year were ¥1,394.651 million, accounting for 70.7% of total operating expenses. The company also plans to continue accelerating its research and development activities and expects to incur a commensurate level of research and development expenses going forward.」
The company recorded research and development expenses of ¥1,394.651 million, or 70.7% of operating expenses, reaffirming its policy of continuing to accelerate research and development activities. - FY2025-H1AdvancedAnnual report
「The company's total research and development expenses for the interim accounting period were ¥739.576 million (compared with ¥732.257 million in the same period of the previous year). During the interim accounting period, the company promoted research and development as described in “(1) Operating Results.”」
Research and development expenses increased from ¥732.257 million in the same period of the previous year to ¥739.576 million, and the company continued to promote research and development. - FY2024RestatedAnnual report
「The company's total research and development expenses for the fiscal year were ¥1,453.969 million, accounting for 70.0% of total operating expenses. The company plans to continue accelerating its research and development activities and expects to incur a commensurate level of research and development expenses going forward.」
The company recorded research and development expenses of ¥1,453.969 million, or 70.0% of operating expenses, reaffirming its policy of continuing to accelerate research and development activities. - FY2024-Q3RestatedAnnual report
「The company's total research and development expenses for the cumulative third quarter were ¥1,102.155 million (compared with ¥1,131.040 million in the same period of the previous year). During the cumulative third quarter, the company promoted research and development as described in “(1) Operating Results.”」
The company recorded research and development expenses of ¥1,102.155 million. Although this was down year on year, its policy of promoting research and development was reaffirmed. - FY2024-Q1RestatedAnnual report
「The company's total research and development expenses for the cumulative first quarter were ¥348.284 million (compared with ¥370.267 million in the same period of the previous year). During the cumulative first quarter, the company promoted research and development as described in “(1) Operating Results.”」
The company recorded research and development expenses of ¥348.284 million. Although this was down year on year, its policy of continuing to promote research and development was reaffirmed. - FY2023AdvancedAnnual report
「The company has actively conducted research and development since its establishment. Research and development expenses for the fiscal year totaled ¥1,567.247 million, accounting for 71.0% of total operating expenses. The company plans to continue accelerating its research and development activities and expects to incur a commensurate level of research and development expenses going forward.」
Research and development expenses were ¥1,567.247 million, or 71.0% of operating expenses, increasing from the previous fiscal year. The company has maintained its policy of continuing to accelerate research and development activities. - FY2023-Q3AdvancedAnnual report
「The company's total research and development expenses for the cumulative third quarter were ¥1,131.040 million (compared with ¥1,073.275 million in the same period of the previous year). During the cumulative third quarter, the company promoted research and development as described in “(1) Operating Results.”」
Research and development expenses for the cumulative third quarter increased from ¥1,073.275 million in the same period of the previous year to ¥1,131.040 million, and the company continued to promote research and development. - FY2023-Q1RestatedAnnual report
「The company's total research and development expenses for the cumulative first quarter were ¥370.267 million. During the cumulative first quarter, the company promoted research and development as described in “(1) Operating Results.”」
The company recorded research and development expenses of ¥370.267 million in the first quarter, reaffirming its policy of continuing to promote research and development. - FY2022RestatedAnnual report
「The company's total research and development expenses for the fiscal year were ¥1,421.286 million, accounting for 70.9% of total operating expenses. The company plans to continue accelerating its research and development activities and expects to incur a commensurate level of research and development expenses going forward.」
The company recorded research and development expenses of ¥1,421.286 million, or 70.9% of operating expenses, reaffirming its policy of continuing to accelerate research and development activities. - FY2022-Q1RestatedAnnual report
「The company's total research and development expenses for the cumulative first quarter were ¥358.857 million. During the cumulative first quarter, the company promoted research and development as described in “(1) Operating Results.”」
The company recorded research and development expenses of ¥358.857 million for the first quarter, reaffirming its policy of continuing to promote research and development. - FY2021AdvancedAnnual report
「The company's total research and development expenses for the fiscal year were ¥1,523.797 million, accounting for approximately 76.4% of total operating expenses. The company plans to continue accelerating its research and development activities and expects to incur a commensurate level of research and development expenses going forward.」
Research and development expenses were ¥1,523.797 million, or approximately 76.4% of operating expenses, and the policy of accelerating research and development activities has been maintained. - FY2021-Q3AdvancedAnnual report
「The company's total research and development expenses for the cumulative third quarter were ¥1,157.869 million (compared with ¥584.677 million in the same period of the previous year). During the cumulative third quarter, the company promoted research and development as described in “(1) Operating Results.”」
Research and development expenses increased from ¥584.677 million in the same period of the previous year to ¥1,157.869 million, and the company continued to promote research and development. - FY2021-Q2AdvancedAnnual report
「The company's total research and development expenses for the cumulative second quarter were ¥760.365 million (compared with ¥354.987 million in the same period of the previous year). During the cumulative second quarter, the company promoted research and development as described in “(1) Operating Results.”」
Research and development expenses increased from ¥354.987 million in the same period of the previous year to ¥760.365 million, and the company continued to promote research and development. - FY2021-Q1RestatedAnnual report
「The company's total research and development expenses for the cumulative first quarter were ¥360.456 million. During the cumulative first quarter, the company promoted research and development as described in “(1) Operating Results.”」
The company reported research and development expenses of ¥360.456 million for the first quarter and indicated its policy of continuing to promote research and development. - FY2020AdvancedAnnual report
「The company's total research and development expenses for the fiscal year were ¥1,356.646 million, accounting for approximately 80.5% of total operating expenses. The number of employees engaged in research and development at the end of the fiscal year was 48.」
Research and development expenses were ¥1,356.646 million, or approximately 80.5% of operating expenses, and the number of employees engaged in research and development increased to 48. - FY2020-Q3RestatedAnnual report
「The company's total research and development expenses for the cumulative third quarter were ¥584.677 million. During the cumulative third quarter, the company promoted research and development as described in “(1) Operating Results.”」
The company indicated its policy of continuing to promote research and development, with research and development expenses of ¥584.677 million for the cumulative third quarter. - FY2020-Q2RestatedAnnual report
「The company's total research and development expenses for the cumulative second quarter were ¥354.987 million. During the cumulative second quarter, the company promoted research and development as described in “(1) Operating Results.”」
The company indicated its policy of continuing to promote research and development, with research and development expenses of ¥354.987 million for the cumulative second quarter. - FY2019First statedAnnual report
「The company has actively conducted research and development since its establishment. Research and development expenses for the fiscal year totaled ¥640.200 million, accounting for approximately 77.4% of total operating expenses. The company plans to continue accelerating its research and development activities, and expects to incur a commensurate level of research and development expenses going forward.」
Research and development expenses were ¥640.200 million for the fiscal year, or approximately 77.4% of operating expenses, and the company indicated that it plans to continue accelerating research and development.